It was hypothesized that the levels of PTPs and inflammatory cytokines, such as IL-1β and IL-6, in HCC patients with chemotherapy/targeted drug resistance could be detected in tissues and plasma by immunohistochemistry and ELISA, respectively. This evidence concerns the gene IL6 and hepatocellular carcinoma.